Advertisement

Topics

Mobious Genomics Ltd. Company Profile

04:01 EST 14th December 2018 | BioPortfolio

Mobious Genomics is pioneering the development of fundamentally new technologies in the fields of genetic analysis and proteomics.By unifying biological molecular systems and artificial nanostructures, Mobious has created a range of next generation diagnostic and research tools, able to materially outperform current platforms at a fraction of the cost. The group’s research has resulted in new technologies and IP in such fields as single molecule sequencing, sequencing by synthesis, ultra highly multiplexed real-time PCR and affinity acceleration for biochips.
Mobious believes that its technology has the potential to help transform the acquisition and use of genetic knowledge in the global healthcare and detection industries.

Location

University Innovation Centre University of Exeter
Rennes Road
Exeter
EX4 4QJ
United Kingdom

Contact

Phone: 44 (0) 8700 112500
Fax: 44 (0) 8700 112600
Email: contact@mobious.com


News Articles [416 Associated News Articles listed on BioPortfolio]

10X Genomics Prepares to Hire 200 New Employees, Move into Larger Facility

Bay Area-based genomics company 10X Genomics has become one of the fastest growing privately-held companies in the region with an earnings increase of more than 2,000 percent over a three-year period.

Microsoft Genomics Ventures into the Microbiome With Eagle Genomics

LONDON, October 15, 2018 /PRNewswire/ -- Cambridge technology innovators partner with Microsoft Genomics Microbiomic research into immune disorders and antibiotic resistance First microbiome partn...

Festival of Genomics London 2018: the landmark event making genomics mainstream

London, UK, 5th January 2018 / Sciad Newswire / This January sees the third edition of Festival of Genomics London, the largest meeting of its kind in the UK. Following two US editions of the event ...

QUANTUM GENOMICS: Quantum Genomics receives ethics committee approval to initiate clinical study of extended-release firibastat tablets

Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat hypertension and h...

QUANTUM GENOMICS: Quantum Genomics to Host Key Opinion Leader and Investor Event on December 10, 2018

Event Focused on Phase IIb Arterial Hypertension Data opening the way to a pivotal Phase 3 Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in th...

#jobs #lifescience CK Group: Genomics Manufacturing Technician – Hertfordshire

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CK Group: Genomics Manufacturing Technician – Hertfordshire . £18,000:...

UK’s genomics leadership attracts IQVIA investment, regardless of Brexit

Invests in Genomics England alliance, plus clinical trials expansion

Vertex and Genomics Collaborate to use Human Genetics and Data Science to Advance Discovery of Precision Medicines

NewsMulti-year collaboration combines expertise in genomics, machine learning, and drug discovery to identify novel targets for innovative medicines.

Drugs and Medications [0 Results]

None

PubMed Articles [206 Associated PubMed Articles listed on BioPortfolio]

Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR.

Single-cell genomics.

Current Social Media Conversations about Genetics and Genomics in Health: A Twitter-Based Analysis.

The growing availability of genomic information to the public may spur discussion about genetics and genomics on social media. Sites, including Twitter, provide a unique space for the public to access...

Lifestyle Genomics: Addressing the Multifactorial Nature of Personalized Health.

The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results.

Guidelines recommend patients be informed of their incidental results (IR) when undergoing genomic sequencing (GS), yet there are limited tools to support patients' decisions about learning IR. The ai...

Clinical Trials [94 Associated Clinical Trials listed on BioPortfolio]

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

This pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patients with multiple myeloma or p...

GENetic Education Risk Assessment and TEsting Study

The goal of the GENERATE study is to improve genetic testing and cancer prevention in family members of pancreatic cancer patients with identified genetic mutations (inherited changes). Th...

Companies [415 Associated Companies listed on BioPortfolio]

Mobious Genomics Ltd.

Mobious Genomics is pioneering the development of fundamentally new technologies in the fields of genetic analysis and proteomics.By unifying biological molecular systems and artificial nanostructures...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

Center for Genomics and Bioinformatics

Center for Genomics and Bioinformatics The Center for Genomics and Bioinformatics (CGB) was launched in 1997 as a new academic department at the Karolinska Institute. Since then, the department has be...

Front Line Genomics

At Front Line Genomics our mission is to help deliver the benefits of genomics faster. Through our website, our magazine and the Festivals of Genomics, we support scientists, clin...

More Information about "Mobious Genomics Ltd." on BioPortfolio

We have published hundreds of Mobious Genomics Ltd. news stories on BioPortfolio along with dozens of Mobious Genomics Ltd. Clinical Trials and PubMed Articles about Mobious Genomics Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mobious Genomics Ltd. Companies in our database. You can also find out about relevant Mobious Genomics Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record